Atara Biotherapeutics, Inc.
(NASDAQ : ATRA)

( )
ATRA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.71%194.081.3%$552.04m
GILDGilead Sciences, Inc.
-0.96%65.880.9%$365.15m
ALXNAlexion Pharmaceuticals, Inc.
1.06%108.542.0%$324.86m
ILMNIllumina, Inc.
-0.01%300.893.5%$300.98m
BIIBBiogen Inc.
-0.22%236.121.3%$287.87m
CELGCelgene Corporation
-0.02%98.381.3%$282.84m
AAgilent Technologies, Inc.
-1.01%77.111.6%$191.08m
SRPTSarepta Therapeutics, Inc.
1.19%87.0214.7%$182.45m
VRTXVertex Pharmaceuticals Incorporated
1.49%177.551.9%$176.25m
REGNRegeneron Pharmaceuticals, Inc.
1.52%285.892.6%$174.13m
EXASExact Sciences Corporation
-2.16%104.4124.1%$129.19m
ACADACADIA Pharmaceuticals Inc.
8.80%44.0113.9%$107.31m
INCYIncyte Corporation
2.50%78.342.5%$85.51m
BMRNBioMarin Pharmaceutical Inc.
2.15%74.214.3%$77.79m
NKTRNektar Therapeutics
5.52%21.225.5%$63.53m

Company Profile

Atara Biotherapeutics, Inc. operates as a clinical stage company which focuses on developing novel therapeutics for serious unmet medical needs, with an initial focus on muscle wasting conditions and oncology. Its product candidates are biologics targeting myostatin and activin, members of the transforming growth factor-beta, protein superfamily, which play roles in the growth and maintenance of muscle and many other body tissues. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA.